Postpartum hemorrhage in developing countries: Is the public health community using the right tools?

International Journal of Gynecology and Obstetrics

Volumn 85, Issue 1 SUPPL., 2004, Pages

  Tsu, V D ^a   Langer, A ^b   Aldrich, T ^b  

^a PATH   (United States)

^b POPULATION COUNCIL   (Mexico)

Author keywords

Developing countries; Misoprostol; Oxytocin; Postpartum hemorrhage; Third stage labor; Uniject

Indexed keywords

CARBOPROST; COPPER SULFATE; ERGOMETRINE; METHYLERGOMETRINE; METHYLERGOMETRINE MALEATE; MISOPROSTOL; OXYTOCIC AGENT; OXYTOCIN; PROSTAGLANDIN E1 DERIVATIVE;

ANEMIA; BLOOD TRANSFUSION; CLINICAL TRIAL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; CUFF; DEVELOPING COUNTRY; DOSE RESPONSE; DRUG COST; ERYTHROCYTE; FEVER; HEMOGLOBIN DETERMINATION; HUMAN; IRON THERAPY; MATERNAL MORBIDITY; MATERNAL MORTALITY; NAUSEA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RISK FACTOR; SHIVERING; SIDE EFFECT; UMBILICAL VEIN; VAGINA BLEEDING; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 2442458939     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2004.02.009     Document Type: Conference Paper

References (83)

1. World Health Organization. Mother-baby package (WHO/RHT/MSM/94.11, Rev1). 1998;WHO, Geneva
2. AbouZahr C. Antepartum and postpartum hemorrhage. Murray C.L., Lopez A.D. Health dimensions of sex and reproduction. 1998;172-174 Harvard University Press, Boston
3. Pritchard J.A. Changes in blood volume during pregnancy. Anesthesiology. 26:1965;393
4. Rogers J., Wood J., McCandlish R., Ayers S., Truesdale A., Elbourne D. Active versus expectant management of third stage of labour: the Hinchingbrooke randomized controlled trial. Lancet. 351:1998;693-699
5. World Health Organization. Managing complications in pregnancy and childbirth: a guide for midwives and doctors. WHO/RHR/00.7. 2000;S25-S34 WHO, Geneva
6. Obstetrical hemorrhage. Cunningham F.G., Gant N.F., Gilstrap L.C., Hauth J.C., Leveno K.J., Wenstrom K.D. Williams obstetrics. 21st:2001;619-669 McGraw-Hill Professional, New York
7. Maine D., Rosenfield A., McCarthy J., Kamara A., Lucas A.O. Safe motherhood programs: options and issues. 1991;New York, Columbia University
8. Carroli G., Rooney C., Villar J. How effective is antenatal care in preventing maternal mortality and serious morbidity? An overview of the evidence. Pediatr Perinat Epidemiol. 15:(Suppl):2001;1-42
9. Rush D. Nutrition and maternal mortality in the developing world. Am J Clin Nutr. 72:(Suppl):2000;212S-240S
10. Lops V.R., Hunter L.P., Dixon L.R. Anemia in pregnancy. Am Fam Physician. 51:1995;1189-1197
11. Brabin B.J., Hakimi M., Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. J Nutr. 131:2001;604S-615S
12. Shane B. Preventing postpartum hemorrhage: managing the third stage of labor. Outlook (Maternal and Neonatal Health Special Issue), Seattle: PATH 2001;19(3):1-8
13. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour (Cochrane Review). The Cochrane Library, Issue 1, 2002. Oxford: Update Software
14. Festin M.R., Lumbiganon P., Tolosa J.E., Finney K.A., Ba-Thike K., Chipato T., et al. International survey on variations in practice of the management of the third stage of labour. Bull World Health Org. 81:2003;286-291
15. Riley D.P., Burgess R.W. External abdominal aortic compression: a study of a resuscitation manoeuvre for postpartum hemorrhage. Anaesth Intensive Care. 22:(5):1994;571-575
16. Akhter S., Begum M.R., Kabir Z., Rashid M., Laila T.R., Zabeen F. Use of a condom to control massive postpartum hemorrhage. Med Gen Med. 5:(3):2003;38. http://www.medscape.com/viewarticle/459894) (Accessed September 24, 2003
17. Sengeh P., Samai O., Sidique S.K., Kebbie A., Fofana P., Stephens S. Improving blood availability in a district hospital, Bo, Sierra Leone. Int J Gynecol Obstet. 59:(Suppl):1997;S127-S134
18. Fenton P.M. Blood transfusion for caesarean section in Malawi. Anaesthesia. 54:1999;1055-1058
19. Hardy J.F., Fenton P.M. Effectiveness of blood transfusion in Malawi. Anaesthesia. 55:2000;613-614
20. Alderson P, Schierhout G, Roberts I, Bunn F. Colloids versus crystalloids for fluid resuscitation in critically ill patients (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2002
21. Hiippala S. Replacement of massive blood loss. Vox Sanguinis. 74:(Suppl 2):1998;399-407
22. US Dept HHS, PHS, NIH. Transfusion alert: indications for the use of red blood cells, platelets & fresh frozen plasma. November 1997
23. Winslow R.M. Blood substitutes: refocusing an elusive goal. Br J Haematol. 111:2000;387-396
24. Klein H.G. The prospects for red-cell substitutes. N Engl J Med. 342:2000;1666-1668
25. Tsu V.D., Free M.J. Using technology to reduce maternal mortality in low-resource settings: challenges and opportunities. J Am Med Women's Assoc. 57:2002;149-153
26. McDonald S, Prendiville WJ, Elbourne D. Prophylactic syntometrine versus oxytocin for delivery of the placenta (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2003
27. Elbourne DR, Prendiville WJ, Carroli G, Wood J, McDonald S. Prophylactic use of oxytocin in the third stage of labour (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2003
28. Hogerzeil H.V. Instability of (methyl)ergometrine in tropical climates: and overview. Eur J Obstet Gynaecol Reprod Biol. 69:1996;25-29
29. Tsu V.D., Sutanto A., Vaidya K., Coffey P., Widjaya A. Oxytocin in pre-filled Uniject™ injection devices for managing third-stage labor in Indonesia. Int J Gynecol Obstet. 83:2003;103-111
30. Bergstrom S, 2003, personal communication
31. Roman A., Rebarber A. Seven ways to control postpartum hemorrhage. Cont Ob/Gyn. 48:(3):2003;34-53
32. Goldberg A.B., Greenberg M.B., Darney P.D. Misoprostol and pregnancy. New Engl J Med. 344:2001;38-47
33. Chanpong G, 2003, personal communication
34. Global Network for Women's and Children's Health Research. (http://gn.rti.org/resunits/index.cfm?fuseaction=site8abstract) (accessed 19/3/2003)
35. Gülmezoglu A.M., Villar J., Ngoc T.N., Piaggio G., Carroli G., Adetoro L., et al. WHO multicentre randomized trial of misoprostol in the management of the third stage of labour. Lancet. 358:2001;689-695
36. Ng P.S., Chan A.S., Sin W.K., Tang L.C., Cheung K.B., Yuen P.M. A multicenter randomized controlled trial of oral misoprostol and IM syntometrine in the management of the third stage of labour. Hum Reprod. 16:2001;31-35
37. Hofmeyr G.J., Nikodem V.C., de Jager M., Gelbart B.R. A randomized placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol. 105:1998;971-975
38. Amant F., Spitz B., Timmerman D., Corremans A., Van Assche F.A. Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomized trial. Br J Obstet Gynaecol. 106:1999;1066-1070
39. Lumbiganon P., Hofmeyr J., Gülmezoglu A.M., Pinol A., Villar J. Misoprostol dose-related shivering and pyrexia in the third stage of labour. WHO Collaborative Trial of Misoprostol in the Management of the Third Stage of Labour. Br J Obstet Gynaecol. 106:1999;304-308
40. El-Refaey H., Nooh R., O'Brian P., Abdalla M., Geary M., Walder J., et al. The misoprostol third stage of labour study: a randomized controlled comparison between orally administered misoprostol and standard management. Br J Obstet Gynaecol. 107:2000;1104-1110
41. Gerstenfeld T.S., Wing D.A. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery. Am J Obstet Gynecol. 185:2001;878-882
42. Hofmeyr G.J., Nikodem V.C., de Jager M., Drakely A. Side-effects of oral misoprostol in the third stage of labour - a randomized placebo-controlled trial. S Afr Med J. 91:2001;432-435
43. Kundodyiwa T.W., Majoko F., Rusakaniko S. Misoprostol versus oxytocin in the third stage of labor. Int J Gynecol Obstet. 75:2001;235-241
44. Gülmezoglu AM, Forna F, Villa J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2002
45. Walley R.L., Wilson J.B., Crane J.M., Matthews K., Sawyer E., Hutchens D. A double-blind placebo controlled randomized trial of misoprostol and oxytocin in the management of the third stage of labour. Br J Obstet Gynecol. 107:2000;1111-1115
46. Surbek D.V., Fehr P.M., Hosli I., Holzgreve W. Oral misoprostol for third stage of labor: A randomized placebo-controlled trial. Obstet Gynecol. 94:1999;255-258
47. Karkanis S.G., Caloia D., Salenieks M.E., Kingdom J., Walker M., Meffe F., et al. Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management. J Obstet Gynecol Can. 24:2002;149-154
48. Wright J.M., Newton W. Is rectal misoprostol as effective as oxytocin in preventing postpartum hemorrhage? J Fam Pract. 52:2003;281-282
49. Caliskan E., Meydanli M.M., Dilbaz B., Aykan B., Sonmezer M., Haberal A. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial. Am J Obstet Gynecol. 187:2002;1038-1045
50. O'Brien P., El-Refaey H., Gordon A., Geary M., Rodeck C.H. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol. 92:1998;212-214
51. Mousa HA, Alfirevic, Z. Treatment for primary postpartum haemorrhage (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2003
52. Lokugamage A.U., Sullivan K.R., Niculescu I., Tigere P., Onyangunga F., El Refaey H., et al. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary postpartum hemorrhage. Acta Obstet Gynecol Scand. 80:(9):2001;835-839
53. Abdel-Aleem H., El-Nashar I., Abdel-Aleem A. Management of severe postpartum hemorrhage with misoprostol. Int J Gynecol Obstet. 72:(1):2001;75-76
54. Goldberg A.B., Greenberg M.B., Darney P.D. Misoprostol and pregnancy. New Engl J Med. 344:(1):2001;38-47
55. Hofmeyr GJ. Obstructed labor: Using better technologies to reduce mortality. Int J Gynecol Obstet 2004(Suppl); in press
56. Chua S., Chew S.L., Yeoh C.L., Roy A.C., Ho L.M., Selamat N., et al. A randomized controlled study of prostaglandin 15-methyl F2 alpha compared with syntometrine for prophylactic use in the third stage of labour. Aust N Z J Obstet Gynaecol. 35:1995;413-416
57. Lamont R.F., Morgan D.J., Logue M., Gordon H. A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage. Prostaglandins Other Lipid Mediat. 66:2001;203-210
58. Granstrom L., Ekman G., Ulmsten U. Intravenous infusion of 15 methyl-prostaglandin F2Ia (Prostinfenem-R) in women with heavy post-partum hemorrhage. Acta Obstet Gynecol Scand. 68:1989;365-367
59. Hayashi R.H., Castillo M.S., Noah M.L. Management of severe postpartum hemorrhage with a prostaglandin F2a analogue. Obstet Gynecol. 63:1984;806-808
60. Oleen M.A., Mariano J.P. Controlling refractory atonic postpartum hemorrhage with Hemabate sterile solution. Am J Obstet Gynecol. 162:1990;205-208
61. Laajoki V.I., Kivikoski A.I. Sulprostone in the control of postpartum haemorrhage. Acta Chir Hung. 27:1986;165-168
62. 2. Am J Obstet Gynecol. 162:1990;694-696
63. Hertz R.H., Sokol R.J., Dierker L.J. Treatment of postpartum uterine atony with prostaglandin E2 vaginal suppositories. Obstet Gynecol. 56:1980;129-130
64. Hensleigh P.A. Anti-shock garment provides resuscitation and haemostasis for obstetric hemorrhage. Br J Obstet Gynaecol. 109:2002;1377-1384
65. Pearse C.S., Magrina J.F., Finley B.E. Use of MAST suit in obstetrics and gynecology. Obstet Gynecol Surv. 39:(7):1984;416-422
66. Hall M., Marshall J.R. The gravity suit: a major advance in management of gynecologic blood loss. Obstet Gynecol. 53:(2):1979;247-250
67. Mud H.J., Schattenkerk M.E., DeVries J.E., Bruining H.O. Nonsurgical treatment of pelvic hemorrhage in obstetric and gynecologic patients. Crit Care Med. 15:1987;534-535
68. Carroli G, Bergel E. Umbilical vein injection for management of retained placenta (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 2001
69. Carroli G., Belizan J.M., Grant A., Gonzalez L., Campodonico L., Bergel E., et al. Intra-umbilical vein injection and retained placenta: evidence from a collaborative large randomised controlled trial. Br J Obstet Gynaecol. 105:1998;179-185
70. Gazvani M.R., Luckas M.J.M., Drakeley A.J., Emery S.J., Alfirevic Z., Walkinshaw S.A. Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial. Obstet Gynecol. 91:1998;203-207
71. Sivalingam N., Surinder S. Is there a place for intra-umbilical oxytocin for the management of retained placenta? Med J Malaysia. 56:2001;451-459
72. Habek D., Hrgovic Z., Ivanisevic M., Delmis J. Treatment of a retained placenta with intraumbilical oxytocin injection. Zentralbl Gynakol. 123:2001;415-417
73. Kovavisarach E., Rojsangruang S. Effect of umbilical vein oxytocin injection on the third stage of labor: a randomized controlled study. J Med Assoc Thai. 81:1998;693-697
74. Purwar, M., Injection into umbilical vein for management of retained placenta: commentary (17 Nov 2000). WHO Reproductive Health Library No. 4, Oxford: Update Software.
75. Paddle J.J. Evaluation of the Haemoglobin Colour Scale and comparison with the HemoCue haemoglobin assay. Bull World Health Org. 80:2002;813-816
76. Lewis S.M., Stott G.J., Wynn K.J. An inexpensive and reliable new haemoglobin colour scale for assessing anaemia. J Clin Pathol. 51:1998;21-24
77. Van den Broek N.R., Ntonya C., Mhango E., White S.A. Diagnosing anaemia in pregnancy in rural clinics: assessing the potential of the Haemoglobin Colour Scale. Bull World Health Org. 77:1999;15-21
78. Stott G.J., Lewis S.M. A simple and reliable method for estimating haemoglobin. Bull World Health Org. 73:1995;369-373
79. Author A. The haemoglobin colour scale: a new tool for detecting anaemia. Safe Motherhood Newslett. 1:2002;13
80. Miraillet J, 2003, personal communication
81. Pistorius L.R., Funk M., Pattinson R.C., Howarth G.R. Screening for anemia in pregnancy with copper sulfate densitometry. Int J Gynecol Obstet. 52:1996;33-36
82. Maharaj N.R., Moodley J. Copper sulphate densitometry: a screening tool for anaemia in rural antenatal clinics. Trop Doctor. 31:2001;171-173
83. Nestel P., Taylor H. Anemia detection methods in low-resource settings: a manual for health workers. 1997;PATH, OMNI